Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cemtrex Inc (CETX)

Cemtrex Inc (CETX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cemtrex’s Advanced Industrial Services Awarded $4.7 Million Large-Scale Infrastructure Contract GlobeNewswire - Tue Oct 8, 8:00AM CDT

CETXW : 0.01 (-30.27%)
CETX : 0.2520 (-6.15%)
CETXP : 0.0320 (-48.05%)
Cemtrex to Host Third Quarter 2022 Financial Results Conference Call on August 15th Globe Newswire - Mon Aug 8, 2022

Brooklyn, NY, Aug. 08, 2022 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things...

CETX : 0.2520 (-6.15%)
CETXP : 0.0320 (-48.05%)
Cemtrex to Present at LD Micro Invitational XII Conference on June 8, 2022 Globe Newswire - Wed May 25, 2022

Brooklyn, NY, May 25, 2022 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things...

CETX : 0.2520 (-6.15%)
CETXP : 0.0320 (-48.05%)
Cemtrex Reports Second Quarter 2022 Financial Results Globe Newswire - Tue May 17, 2022

Second Quarter Revenues Increase 37% to $12.7 Million...

CETX : 0.2520 (-6.15%)
CETXP : 0.0320 (-48.05%)
Cemtrex Announces New Strategic Focus to Address Significant Near-Term Opportunities Globe Newswire - Wed May 4, 2022

Evaluating a Range of Operational and Financial Alternatives Including the Sale of One Or More of the Company’s Business Units...

CETX : 0.2520 (-6.15%)
CETXP : 0.0320 (-48.05%)
Cemtrex Announces $1.2 Million Upgrade Order in Advanced Technologies Segment Globe Newswire - Tue Mar 22, 2022

Corrections Facility in Oregon to Upgrade Security Surveillance System...

CETX : 0.2520 (-6.15%)
CETXW : 0.01 (-30.27%)
CETXP : 0.0320 (-48.05%)
Cemtrex Reports First Quarter 2022 Financial Results Globe Newswire - Tue Feb 22, 2022

First Quarter Revenues Increase 21% to $10.7 Million...

CETX : 0.2520 (-6.15%)
Cemtrex Announces Strategic Follow-On Investment into Masterpiece Studio Globe Newswire - Wed Feb 2, 2022

Additional $500K brings total investment to $1.0 M to Fund Leading 3D Content Development Platform for Virtual Reality and the Metaverse...

CETX : 0.2520 (-6.15%)
CETXW : 0.01 (-30.27%)
CETXP : 0.0320 (-48.05%)
OnXRP and Cemtrex Announce Partnership To Further Develop The onXRP.COM Platform Globe Newswire - Wed Jan 26, 2022

Brooklyn, NY, Jan. 26, 2022 (GLOBE NEWSWIRE) -- onXRP.com, a leading technology and content platform which provides user-driven innovation to the XRP...

CETX : 0.2520 (-6.15%)
CETXW : 0.01 (-30.27%)
CETXP : 0.0320 (-48.05%)
Cemtrex Announces Receipt of Nasdaq Listing Delinquency Letter and Has Subsequently Regained Compliance Globe Newswire - Tue Jan 25, 2022

Brooklyn, NY, Jan. 25, 2022 (GLOBE NEWSWIRE) --  — Cemtrex Inc. (NASDAQ: CETX, CETXP, CETXW), a technology company driving innovation in Internet of...

CETX : 0.2520 (-6.15%)
CETXW : 0.01 (-30.27%)
CETXP : 0.0320 (-48.05%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot